Phenomic AI Company
Phenomic AI is a developer of a drug discovery platform designed to discovery and optimize therapeutics directly against phenotypic assays.The company's platform uses artificial intelligence to analyze phenotypes in complex disease models including high-content co-culture and 3D assays, enabling pharmaceutical companies to discover drugs in an easier way.
Investors
(INV).png)
.png)
.png)
.png)
(Reupload).png)
.jpeg)
Technology:
Artificial Intelligence, Biotechnology, Information Technology, Machine Learning
Industry:
Early Drug Development
Headquarters:
Toronto, Ontario, Canada
Founded Date:
2017-01-01
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
13
Total Funding:
11391214
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-10-07
Last Funding Type:
Seed
Register and Claim Ownership